Tyrosine phosphorylation is one of the major mechanisms involved in the intracellular propagation of external signals. Strategies aimed at interfering with this process might allow the control of several cellular phenotypes. SH2 domains mediate protein ± protein interactions by recognizing phosphotyrosine (pY) residues in the context of speci®c phosphopeptides. We created an SH2-scaolded repertoire library by randomly mutagenizing ®ve critical amino acid positions in the speci®city-determining region of the PLCg C-terminal SH2 domain. Synthetic SH2 domains were selected from the library using biotinylated phosphopeptides derived from a natural PLCg-SH2 ligand as well as unrelated SH2 ligands. The isolated SH2s displayed high binding anity constants for the selecting peptides and were capable of interacting with the corresponding proteins. Oncogene (2001) 20, 5186 ± 5194.
Introduction
Activation of tyrosine kinases (TK) plays a major role in several aspects of cellular homeostasis, including proliferation, dierentiation and apoptosis. Several neoplastic and non-neoplastic pathological conditions are caused by subversion of these basic cellular processes. The propagation of signals originating from both receptor and non-receptor tyrosine kinases relies on the phosphorylation of intracellular substrates, which in turn mediate downstream eects. The identi®cation of the complete repertoire of phosphotyrosine (pY)-containing proteins is therefore one of the major outstanding issues in cell biology. Furthermore, molecular devices that can speci®cally target individual pY-containing proteins should permit interference with TK-based signaling pathways, ultimately providing a basis for the rational design of molecular therapeutics.
Natural pY-targeting devices exist and are constituted by SH2 and PTB/PID domains (Shoelson, 1997) , they mediate interactions between pY residues and target proteins harboring either domain. SH2 and PTB domains have evolved to recognize selectively pY residues within unique amino acid contexts. In particular, residues immediately distal to the pY residue determine binding speci®city and anity of phosphopeptides for SH2 domains. Optimal binding motifs for several SH2 domains were determined by screening of phosphopeptide libraries (Songyang et al., 1993) . The molecular determinants of SH2 domains that direct the recognition of phosphopeptides have also been de®ned. They include a conserved pocket that accommodates the pY residue, and a number of variable residues that contact other residues in the phosphopeptide, thus directing the speci®city of the interaction (Kuriyan and Cowburn, 1997) . Comparison of several resolved structures of SH2s reveals that amino acid residues at ®ve positions (bD5, bE4, EF1, BG2 and BG3, named according to Eck et al. (1993) have the greatest impact in establishing contacts with the phosphopeptide (Breeze et al., 1996; Eck et al., 1993; Hatada et al., 1995; Lee et al., 1994; Narula et al., 1995; Pascal et al., 1994; Rahuel et al., 1996; Waksman et al., 1993) .
It has been shown that it is possible to alter phosphopeptide selectivity between two SH2 domains, by replacing single residues at critical positions. A Src SH2 domain mutant, bearing a W at EF1 position, instead of the natural T, selected a Grb2 SH2-binding consensus peptide. Similarly, mutation of the amino acid at bD5 in the p85 or PLC-g SH2 domains resulted in the acquired ability to recognize a Src SH2-binding peptide (Marengere et al., 1994; Songyang et al., 1995) . Thus, in principle, a repertoire of SH2s could be created by randomly replacing a number of amino acid residues at critical positions in a given SH2 scaold. Such a library should contain synthetic SH2s capable of interacting with most, if not all, pY-containing peptides, even those for which no natural SH2 partners exist. The general feasibility of such an approach has been recently demonstrated for the PDZ domain, by employing a two step protocol in which random mutagenesis was followed by yeast two-hybrid selection (Schneider et al., 1999) . This led to the isolation of synthetic PDZs with novel binding speci®cities. The detailed structural knowledge, available for SH2 domains, permits a comprehensive rational`patch engineering' approach, which can exploit targeted mutagenesis of the ®ve most critical amino acid positions, rather than random mutagenesis. In this study we adopted such a strategy to generate and to validate an SH2-scaolded repertoire library.
Results

Engineering of an SH2-scaffolded library
A two-component model of binding explains the SH2:pY peptide interaction. An energetically favorable interaction is established between the phosphotyrosine residue and the highly conserved pY binding pocket in SH2s domains (Figure 1a) . Simultaneously, several bonds are established among residues distal to the pY residue of the phosphopeptide and amino acids located in the speci®city-determining pocket of the SH2 domain. These latter contacts determine the speci®city and the strength of the interaction between a given SH2 domain and a binding phosphopeptide. In order to create a repertoire of SH2 domains with dierent and multiple binding abilities, we tested the possibility of arti®cially modifying the speci®city-determining region of an SH2 by mutagenizing critical amino acids. The C-terminal SH2 of PLC-g was chosen as a scaold for the library because of the great wealth of structural and functional information available for this domain (Carpenter and Ji, 1999; Pascal et al., 1994) .
A three-dimensional model of the PLC-g SH2 domain derived from NMR coordinates (Pascal et al., 1994) is shown in Figure 1a . The ®ve critical amino acids contacting the phosphopeptide and their positions (C at bD5, L at bE4, G at EF1, L at BG2 and Y at BG3) are indicated, together with the interactions between the domain and a target phosphopeptide (in this case PDGFR-pY1021, identical to the sequence of the PDGF receptor surrounding pY 1021). To create the synthetic SH2 repertoire, we randomly mutagenized the indicated ®ve amino acids with degenerated oligonucleotides (see Materials and methods). The resulting library was subcloned in the pGEX vector, in frame with the GST moiety. Nucleotide sequence of 100 randomly isolated clones showed the expected sequence randomization (Figure 1b) in 62% of the cases. The remaining clones (38%) consisted of cloning artifacts, including single base insertions or deletions. The integrity of the phosphotyrosine (pY) binding pocket and the proper folding of the synthetic SH2 domains were evaluated by recovering of GST-fusion domains by pY-agarose beads. All of the analysed SH2s (12/12 randomly selected clones among the correct ones) were able to bind to pY agarose with eciencies comparable to that displayed by the wt PLC-g SH2 scaold (data not shown). We concluded that we had generated a bona ®de repertoire of synthetic SH2s.
We initially screened the GST-SH2 library with a cognate peptide for the wt PLC-g SH2 (Larose et al., 1993) . This peptide, PDGFR-pY1021, selected 14 synthetic SH2s. Of these, one displayed a sequence identical to wt PLC-g, thus demonstrating the ability of our screening approach to recover`legitimate' binders ( Table 1 ). The other 13 clones displayed overall similarity to the wt scaold and identi®ed a consensus (at a plurality of 450%) f/f/G/f/ Ar (HydrophobicHydrophobic -Glycine -Hydrophobic -Aromatic) that underscored a limited degree of accepted variability in the ®ve critical binding residues compatible with binding to PDGFR-pY1021 (Table 1) .
Novel specificities in the SH2-scaffolded repertoire library
To search for novel speci®cities contained in our SH2 repertoire, we screened the library with heterologous phosphopeptides known to bind to SH2s other than the PLC-g SH2. Initially we employed a phosphopeptide (mTAg-pY324) corresponding to the optimal binding sequence of the polyoma middle T antigen for the SH2 domain of Lck (Songyang et al., 1993) . This phosphopeptide selected seven SH2s identical to the wt PLC-g SH2 and 10 novel SH2s, displaying the consensus, V/f/G/L or F/f (Table 2 ). This consensus showed remarkable similarity to the wt PLC-g scaold and no similarity to the corresponding positions in the Lck SH2. A possible explanation for this phenomenon is discussed subsequently.
Two phosphopeptides (PDGFR-pY716 and ShcpY239) known to bind to the SH2 of Grb2 were also used (Arvidsson et al., 1994; van der Geer et al., 1996) . These peptides are structurally dierent with the exception of an asparagine residue at the +2 position, with respect to the pY residue, in both peptides. This residue is known to direct the speci®city of binding to the SH2 of Grb2. Remarkably, in our screenings, the two peptides selected similar synthetic SH2s (Table 3 ), suggesting that the molecular constraints of the SH2-phosphopeptide interaction are maintained in our screening conditions. The derived consensus showed how precise substitutions could change the scaold into a Grb2-like SH2 domain (Table 3) . It has been shown that the presence of a W at the EF1 position, in the Grb2 SH2 domain, induces a b-turn conformation in the phosphopeptide preventing its binding in the extended conformation that is typical of other SH2 domain-peptide interactions. The turn conformation of the phosphopeptide is then stabilized by contacts between its N at the +2 position and amino acid residues (K at bD6 and L at bE4) of the Grb2 SH2 domain (Ogura et al., 1999; Rahuel et al., 1996) . Results from our screenings raise the interesting possibility that the almost obligatory presence of a W at BG3, in the synthetic Grb2-like domains, might substitute for the W present in the EF loop of the natural Grb2 SH2. Elements of the secondary structure are indicated using the standard SH2 notation. The phosphotyrosine-binding pocket and the speci®city-determining pocket are positioned on the left and on the right of the central bsheet, respectively. The side chains of the ®ve amino acids (C at bD5, L at bE4, G at EF1, L at BG2 and Y at BG3) which were mutagenized to generate the library are shown in a stick representation. The phosphotyrosine residue (pY) in the peptide is also indicated. The model was generated using MOLSCRIPT (Kraulis, 1991) and Raster3D (Merit and Murphy, 1994) from NMR coordinates 2PLD (Pascal et al., 1994) . ( 
Kinetic analysis of the association between synthetic SH2s and peptides
Equilibrium dissociation constant and kinetic parameters of the interactions between synthetic SH2s and their peptides were derived using Surface Plasmon Resonance (Biacore) analysis. All the synthetic SH2s displayed binding anities for the screening peptides comparable to those shown by the same peptides for their cognate`physiological' SH2s, Lck or Grb2 (Table  4) . Surprisingly, all of the synthetic SH2s retained the ability to bind to PDGFR-pY1021, the cognate peptide for the wt PLC-g SH2, with anities comparable to that of the wt scaold (Table 5 ). Thus, under our conditions, the engineering of an SH2 repertoire library resulted in the creation of synthetic SH2s with at least dual binding speci®city.
Close inspection of the kinetic parameters provided insights into the events leading to the selection of certain synthetic SH2s by our screening peptides. The mTAg-pY324 peptide, for instance, displayed high binding anity to the wt PLC-g scaold (Table 4) , which was only one order of magnitude below that displayed for its cognate`physiological' Lck SH2. mTAg-pY324-selected synthetic SH2s, on the other hand, displayed K D s for the selecting peptide (mTAgpY324) comparable to that of the Lck SH2:mTAgpY324 interaction. Thus, in the repertoire library, some synthetic SH2s were created in which the already considerably strong binding of the wt PLC-g scaold to the mTAg-pY324 peptide was`optimized' by certain amino acid substitutions. This explains the selection of wild type PLC-g SH2, and of other synthetic SH2s with a very similar consensus, by the mTAg-pY324 peptide. Furthermore, these results point to the relative binding promiscuity of the PLC-g SH2 and to the relevance of subtle dierences (for instance the V/I for C substitution at bD5, in this particular case) in modifying its anity for a given peptide.
At variance with mTAg-pY324 selected clones, PDGFR-pY716-selected SH2s had acquired an additional novel speci®city, since the wt PLC-g scaold was unable to interact with the PDGFR-pY716 phosphopeptide (Table 4) . These synthetic SH2s displayed K D values comparable to those obtained by measuring the interaction of PDGFR-pY716 with the cognate Grb2 SH2. Of note, the measured K D s for the interaction with the PDGFR-pY716 peptide, both of the wt Grb2 
Predicted amino acid residue at each indicated mutagenized positions derived from sequencing of the selected clones. Residues of the PLC-g scaold and Lck SH2 are also indicated. 
ShcpY239 phosphopeptide: EPPDHQpYpYNDPFPGKE.
c Predicted amino acid residue at each indicated mutagenized positions derived from sequencing of the selected clones. Residues of the PLC-g scaold and Grb SH2 are also indicated. and of the synthetic SH2s, were in the high nM range (400 ± 600 nM), indicating additional requirement for PDGFR sequences, outside of the binding peptide, to determine optimal anity in vivo.
Technical problems prevented us from performing Biacore analysis of the interaction between the ShcpY239 phosphopeptide and its selected synthetic SH2s. To circumvent this problem, we employed another Shcderived phosphopeptide (Shc-pY317), also known to bind to Grb2 (Salcini et al., 1994) . Synthetic SH2s selected by Shc-pY239, displayed a hierarchy of anities for Shc-pY317 (Table 4 ). In particular, while two of the synthetic SH2s showed a K D for Shc-pY317 indistinguishable from that of the wt PLC-g scaold (Table 4) , two others exhibited a 10-fold higher anity for the peptide. This latter value was comparable to that of the interaction between Shc-pY317 and its cognate Grb2-SH2 domain.
Finally, we noticed that while all of the synthetic SH2s exhibited K D s typical of natural SH2 domains, these values were however the result of altered kinetic parameters, i.e. higher association and higher dissociation rates. Figure 2 shows the SPR sensograms of the entire set of curves used to derive kinetic parameters of the interaction between the PDGFR-pY716 peptide and the Grb2 SH2 and VVDIW, respectively. Assuming a simple binary-reaction model, a ®vefold increase in the time required to reach equilibrium was calculated for the interaction GRB2 SH2:PDGFRpY716 with respect to the VVDIW SH2:PDGFRpY716 one.
Synthetic SH2s bind to native proteins
To test the acquired binding speci®city of our selected clones in a more physiological context, we investigated their ability to bind to native proteins. Synthetic Grb2-like GST-SH2s were immobilized onto agarose-GSH and used as an anity tool to recover Shc proteins present in cellular lysates. Two of the synthetic SH2s were able to bind to Shc with eciencies indistinguishable from that of a wt Grb2-SH2 (Figure 3a) . Two others displayed marginal binding, which was comparable to that exhibited by the wt PLC-g scaold (Figure 3a) . Of note, these in vitro binding data were concordant with the anities measured by Biacore analysis (Table 4 ). The overall sequence similarity between the high-and relatively lower-anity Grb2-like SH2s (compare for example VVDIW to ITRIW) further suggests that determination of the structure of these synthetic SH2s complexed to their peptides should provide important insights in the understanding of the structure/function relationships in the SH2 family of domains. We next investigated whether the synthetic SH2s had acquired dierent binding speci®cities towards the naturallyoccurring repertoire of pY-containing proteins. To this end, we incubated GST-SH2s with cellular lysate from cells which have been treated with tyrosine phosphatase inhibitors to increase the level of tyrosine phosphorylation in vivo. As shown in Figure  3b , the pattern of pY-proteins recovered onto synthetic SH2 displayed qualitative and quantitative dierences, with respect to that recovered by the wt PLC-g scaold. 
Discussion
By generating a repertoire library, we demonstrated that synthetic SH2s, with altered recognition speci®city, could be isolated by probing with phosphopeptide ligands that were non-cognate for the wt SH2 scaold used to engineer the library. While our studies represent an initial exploration into the possibilities aorded by an SH2 repertoire library, some interesting concepts emerge from the analysis of the data. The most intriguing, and somewhat unexpected observation, is that rather than creating synthetic SH2s with exclusive novel speci®city, we obtained modules with dual speci®city, in which, as a result of few amino acidic substitutions, additional high-anity binding sites emerged without ablating the innate recognition ability of the original scaold. The most obvious explanation for this phenomenon might be that the ®ve positions that we mutagenized are not sucient to subvert completely the molecular constraints on which the high-anity recognition between the PLC-g SH2 and a cognate physiological ligand rests. Evidence in the literature might support this view. In a systematic alanine scanning of all the critical contact positions of the Src SH2, marginal dierences were detected in the binding properties of most (7), were incubated with the indicated GST-SH2 domains. The synthetic SH2s are identi®ed by the amino acid residues present at the mutagenized positions. Puri®ed complexes were detected with an anti-Shc serum. Arrows point to the three isoforms of Shc. The additional band between the 66 and 52 Shc isoforms is of unknown origin. Equal loading of GST in all lanes was controlled by Comassie-Blue staining (not shown). (B) Anity puri®cation of pY-proteins onto GST-SH2s. Hela cells were treated for 12 h with Na 3 VO 4 (200 mM). Total lysate (10 mg) were then anity puri®ed onto SH2 columns in which either GST-SH2 PLC-g (PLC-g) or a synthetic SH2 (VVDIW) were covalently linked to sepharose beads. Speci®cally bound proteins were detected in immunoblot with anti-pY antibodies. The lane`input' was loaded with 1/40th of the starting material. The lanes`c.w.' (column wash) represent last fraction of the column washes, to show no non-speci®c retention of pY-proteins at the end of the washing procedures. Fractions (F1, F2, F3 ) represent the ®rst three fractions eluted with 0.1 M glycine pH2.5. Each fraction consists of 1 ml (0.5 bed volume) and 1/10th was loaded onto the gel. The F2* lane represents a shorter exposure of the F2 lane VVDIW to allow for a more direct comparison with the F2 lane PLC-g. Molecular weight markers are reported in kDa on the left. Arrows point to the most evident dierences between PLC-g and VVDIW mutants with respect to the wt SH2 (Bradshaw et al., 2000) . This might indicate that the overall structure of an SH2, rather that individual amino acid residues, are important in determining the recognition by the speci®city-determining pocket.
An alternative possibility is that SH2 domains have evolved from a rather non-specialized small subset of modules. Evolutionary diversi®cation might have entailed minimal changes that were selected based on their property to leave some interactions unaltered (or less altered), while substantially reducing the anity of others. Under such a scenario, the isolation of back-mutants' with promiscuous behavior, such as ours, would not constitute a totally unexpected occurrence.
Data in this manuscript and in the literature support the above contention. When testing the interaction of the mTAg-pY324 phosphopeptide with the PLC-g SH2, we found a rather strong binding, only one order of magnitude weaker than the one between the same peptide and the physiological lck SH2. Such a dierence might be enough to determine preferential binding in vivo, especially if the concentrations of the two interactors were to be low. Interestingly, minimal changes at some positions in the speci®city-determining pocket were able to increase the anity of a PLC-g SH2 scaold for the noncognate peptide, making it indistinguishable from a cognate interaction. In previously published studies, it was shown that a C to Y substitution at the bD5 position of the PLC-g C-terminal SH2 yielded a mutant that bound preferentially to a pYEEFcontaining peptide, while loosing the ability to bind to the cognate PDGFR pY1021 peptide (Songyang et al., 1995) . However, the same pYEEF-phosphopeptide could bind to the wt PLC-g SH2 with higher anity that to the C-4Y mutant (Songyang et al., 1995) . In this case, therefore, the newly generated binding speci®city appeared to be due to a dierential reduction in the anities of the modi®ed scaold for dierent pY-containing peptides. The anity for the cognate PDGFR-pY1021 peptide was severely affected, while that for the non-cognate ligand only marginally reduced, giving rise to an apparent change of speci®city. The use of a repertoire library, coupled to structural studies, should therefore greatly aid the understanding of the plasticity of SH2 domains and of how they evolved to achieve optimal recognition of their peptides in vivo.
Another interesting ®nding of our work was that the lower K D s for non-cognate peptides exhibited by synthetic SH2s were caused by altered kinetic parameters, i.e. higher association and dissociation rates. We found intriguing that this was a universal property of all selected synthetic SH2s, as opposed to natural SH2s. Whether this has implication for the in vivo recognition between natural SH2s and their ligands is not known. However, an accurate structural and functional analysis of the cellular basis of the synthetic SH2s-phosphopeptides interactions should shed light on the determinants that in¯uence the association/ dissociation rates of various SH2s and might provide tools to design synthetic modules with desired kinetic parameters.
Finally, the biodiversity obtained through the generation of a synthetic SH2 repertoire, forecasts several interesting applications. Synthetic SH2s might allow the structural de®nition of the determinants required for optimal interaction between SH2s and their cognate ligands. This knowledge will be invaluable in designing speci®c inhibitors of the SH2:peptide interaction. Synthetic SH2 domains might also allow the molecular de®nition of cellular pathways which involve signal transduction through tyrosine-phosphorylated intermediates, a goal that can be reached by combining advanced post-genomic approaches such as proteomics and functional assays aimed at interfering with biological processes (proliferation, dierentiation, apoptosis) relevant to human disease. Furthermore, synthetic SH2s should permit pro®ling of the pY-protein expression patterns in pathological conditions, ®rst and foremost in cancer. This might lead to the development of useful molecular diagnostic tools and, through the identi®cation of pY-proteins directly relevant to cancer and other disease, might provide attractive targets for therapy.
Materials and methods
Generation of an SH2-scaffolded library
The bovine PLC-g C-terminal SH2 domain (aa 662 ± 756, gift of Dr Pawson) was cloned in a modi®ed pGEX vector (pGEX-KT) between the BamHI and EcoRI sites. Mutagenesis of residue 705 allowed the creation of a unique HindIII site, without altering the predicted protein sequence. The region between amino acids 705 ± 756 was mutagenized with two degenerate oligonucleotides (of 110 and 88 nucleotides in length) with an overlapping region of 25 nucleotides, which were annealed and extended with T7 Sequenase 2.0 polymerase. The mutagenizing oligonucleotides, covering the C terminal portion of the PLC-g SH2 (amino acids 705 ± 756) were designed in a way to minimize the introduction of stop codons at the degenerate positions. The sequences of the oligos were: (i) oligo 110 nc, 5'GCCATAAGCTTCCGGG-CTGAGGGCAAGATCAAGCACNNSCGCGTCCAGCA-GGAGGGCCAGACCGTGATGNNSNNSAACTCAGAG-TTTGACAGCCTTGTCGACCTCATCAG3'; (ii) oligo 88 nc, 5'ATGAATTCTCAGATGGGGTAGCGCAGCTTC-ATCTTGCGSNNSNNTGGGTGCTTCTCGTAGTAGCT-GATGAGGTCGACAAGGCTGTCAA3' (N=for any base, S=C or G). They were purchased from Integrated DNA Technologies, Inc. The resulting double-stranded DNA fragments were digested with HindIII and EcoRI and subcloned into the HindIII/EcoRI-digested PLC-g SH2 pGEX-KT vector, yielding a library of 5610 4 dierent clones.
Phosphopeptide library screening
The SH2 domain library was plated at 10 4 cells/150 mm plate and screened according to a modi®cation of the method of Ikeda et al. (1996) . Brie¯y, bacteria were lysed in denaturation buer (50 mM Tris-HCl pH 8.0, 7 M Guanidine Hydrocloride, 2 mM EDTA) followed by protein renaturation overnight at 48C in renaturation buer (10 mM Tris-HCl pH 7.5, 40 mM NaCl, 2 mM EDTA, 2 mM DTT, 0.04% Tween 20, 1% BSA). After blocking, ®lters were incubated for 1 h at RT with biotinylated phosphopeptides (50 nM PDGFR-pY1021; 50 nM mTAg-pY324; 500 nM Shc-pY239; 500 nM PDGFR-pY716,) and subsequently with 10 ng/ml of streptavidin horseradish peroxidase, followed by chemiluminescence. Biotinylated PDGFR-pY1021 (EGDNDpYIIPLPDPK) and mTAg-pY324 (EPQpYEEIPIYL) were purchased from Genosys. Shc-pY239 (EPPDHQpYpYNDPFPGKE), Shc-pY317 (GSGSDPSpYVNVQNLDK) and PDGFR-pY716 (PSAELpYSNALPVGLP) were synthesized in solid phase by Fmoc chemistry. Several negative controls were performed, including: binding of pY-peptides to GST alone, and binding of all selected SH2s to nonphosphorylated counterparts of the screening peptides.
Surface Plasmon Resonance experiments and data analysis
Surface Plasmon Resonance analysis was carried out using a Biacore 2000 Apparatus. Biotinylated peptides were immobilized on a streptavidin coated CM5 sensor chip as described elsewhere (Panayotou et al., 1993) . Brie¯y, streptavidin at 100 mg/ml in 20 mM sodium acetate buer, pH 4.5, was injected on the sensor chip surface, previously activated with a 0.05 M NHS/0.2 M EDC mixture. Excess reactive groups were blocked by 1.0 M ethanolamine. GST-SH2 containing solutions were further dialyzed against HBS-EP running buer (20 mM HEPES, 150 mM NaCl, 3.4 mM EDTA, 0.005% Polysorbate20) prior to use. Biotinylated peptides and GST-SH2 fusion proteins were all diluted in HBS-EP running buer. The level of immobilized ligands was carefully determined in order to minimize mass transport limitations and avidity eects due to GST dimerization. PDGFR-pY1021, mTAG-pY324, and ShcpY317 biotinylated peptides were diluted to a ®nal concentration of 10 ng/ml in HBS-EP running buer and injected at a¯ow rate of 5 ml/min until a 10 ± 20 RU response was obtained. These working conditions typically provide a 150 ± 200 RU binding for a 1 mM GST-SH2 solution. Due to the weaker strength of interaction, the PDGFR-pY716 immobilization level was ®xed to 80 ± 120 RU providing maximal binding response (150 ± 200 RU) at a concentration of 10 mM GST-Grb2. Non-speci®c binding was measured and subtracted using a blank cell in which the corresponding unphosphorylated peptides were immobilized. Puri®ed GST-SH2 fusion proteins were injected for 2.5 min at a¯ow rate of 100 ml/min. Dissociation was measured in free HBS-EP buer. Any material remaining bound to the surface after the dissociation phase was removed by a 0.1% SDS regeneration pulse. Several controls were performed in the presence of excess competing peptides during the dissociation phase and, in a few cases, 2 ± 3-fold higher dissociation rates were measured in the presence of very high concentrations of competitor. Thus, kinetic artifacts due to mass transport limitation and/or avidity were negligible under our conditions. For data analysis, dierent procedures were performed in parallel to con®rm validity of the measurements. For each curve, response during dissociation phase was ®tted using a simple exponential function using the BiaEvaluation 2.1 software. The initial seconds of dissociation were excluded from the analysis due to potential in¯uence of the change in the refractive index. Accuracy of the ®t was estimated by the w 2 parameter value, residuals amplitude and distribution of ®rst and second lags. Subsequently, the calculated k o was used to estimate the k on rate. The response during association was ®tted with the following function:
where C is the concentration of the injected SH2; R max is the maximum response obtained at saturating concentrations of analyte; k on , k o are the association and dissociation rates, respectively. Reaction rates were estimated for at least 12 curves corresponding to dierent concentrations of GST-SH2 fusion proteins. Mean rates were used to calculate the dissociation constant (K D ) for the interaction from the formula: K D k off ak o n 2 K D s were also estimated using the standard Scatchard analysis for the equilibrium binding response (0.915R 2 50.98 in all the analysis), deriving the association rate from (2). Essentially similar results were obtained with the two procedures of analysis.
The amount of PDGFR-pY716 immobilized on the sensorchip was almost 10-fold higher with respect to those used for the analysis of other peptides due to relatively reduced anity of interaction. As a consequence, an alternative mathematical model to ®t the reaction kinetics was tested. This took into account the possibility that dimerization of the GST moiety in¯uenced the reaction kinetics. Equations for two-step binding process can be found in the manual of the SPR evolution software used for the analysis available on the WEB (http://www.bri.nrc.ca/csrg/equip.htm). Essentially the scheme is:
where AA is a dimer of GST-SH2 fusion proteins; B is one molecule of ligand on the chip. The ®tting procedure was performed on an entire set of curves, corresponding to injections of analyte at dierent concentrations, and simultaneously for the association and dissociation phases (de®ned Global Analysis by Morton and Myszka, 1998 (Morton and Myszka, 1998) ). In this case, single association and dissociation rates were obtained from an entire set of curves. Correlation matrix of the parameters and correlation coecients, together with statistical analysis of residuals, con®rmed accuracy of the ®t for all the fusion proteins tested.
In vitro binding assay and pY-proteins profiling GST-fusion proteins, encompassing various SH2 domains were prepared according to standard procedures. In vitro pull-down experiments were performed as previously described (Fazioli et al., 1993) . For pY-proteins pro®ling experiments (Figure 3b ), GST-SH2s were crosslinked to sepharose beads according to standard procedures. After anity puri®cation, speci®cally-bound proteins were eluted with 0.1 M glicine pH 2.5.
